|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q89791223
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010857.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q89791223
|
|
024
|
|
|
‡a
0000-0002-2029-5139
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q89791223
|
|
100
|
0 |
|
‡a
Isabela Cunha
‡c
researcher (ORCID 0000-0002-2029-5139)
‡9
en
|
|
400
|
0 |
|
‡a
Isabela Cunha
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's Assessment of somatic mutations in urine and plasma of Wilms tumor patients
|
|
670
|
|
|
‡a
Author's Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma
|
|
670
|
|
|
‡a
Author's NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients
|
|
670
|
|
|
‡a
Author's Profile of patients with penile cancer in the region with the highest worldwide incidence
|
|
909
|
|
|
‡a
(orcid) 0000000220295139
‡9
1
|
|
919
|
|
|
‡a
incidenceanddistributionofuroseekgenepanelinamultiinstitutionalcohortofbladderurothelialcarcinoma
‡A
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma
‡9
1
|
|
919
|
|
|
‡a
ndrg4promoterhypermethylationisamechanisticbiomarkerassociatedwithmetastaticprogressioninbreastcancerpatients
‡A
NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients
‡9
1
|
|
919
|
|
|
‡a
profileofpatientswithpenilecancerintheregionwiththehighestworldwideincidence
‡A
Profile of patients with penile cancer in the region with the highest worldwide incidence
‡9
1
|
|
919
|
|
|
‡a
assessmentofsomaticmutationsinurineandplasmaofwilmstumorpatients
‡A
Assessment of somatic mutations in urine and plasma of Wilms tumor patients
‡9
1
|
|
996
|
|
|
‡2
BNE|XX4766648
|
|
996
|
|
|
‡2
BLBNB|001565898
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
